Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Intravenous Magnesiumsulfate on Postoperative Pain in Patients Undergoing Cesarean Section: The Magnesium for Postoperative Analgesia In the Newly Delivered, The MAG-PAIN Randomized Controlled Trial.

NCT07528612 is registered in ClinicalTrials.gov with Region Halland as lead sponsor.

NCT NCT07528612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07528612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Intravenous Magnesiumsulfate on Postoperative Pain in Patients Undergoing Cesarean Section: The Magnesium for Postoperative Analgesia In the Newly Delivered, The MAG-PAIN Randomized Controlled Trial.
Lead sponsor
Region Halland
Phase
Phase 2
Overall status
Not yet recruiting
Start date
April 2, 2026
Completion date
December 31, 2028
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

magnesium sulfate, pain interference, pain prediction, postoperative pain, quality of recovery (qor-15), self-efficacy